PLUS1
32.32
-0.23 (-0.71%)
-0.23 (-0.71%)
Upgrade to Real-Time
Afterhours
Low
25.925
High
50.26
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| REGENXBIO Inc | RGNX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.23 | -0.71% | 32.32 | 16:00:10 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 32.23 | 31.85 | 33.51 | 32.32 | 32.55 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 31.30 | 37.60 | 6.30 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,113 | 355,273 | $ 32.24 | $ 11,452,299 | - | 25.925 - 50.26 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:19:43 | 38 | $ 32.32 | USD |
Period:
Draw Mode:
REGENXBIO Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.37B | 42.51M | 33.68M | $ 154.57M | $ -97.22M | -2.99 | -10.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 64.00k | 1.10% |
REGENXBIO News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGNX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 37.46 | 37.48 | 31.85 | 33.52 | 362,079 | -5.14 | -13.72% |
| 1 Month | 39.25 | 39.985 | 31.85 | 35.94 | 280,234 | -6.93 | -17.66% |
| 3 Months | 35.34 | 40.83 | 31.85 | 36.60 | 321,250 | -3.02 | -8.55% |
| 6 Months | 42.30 | 49.50 | 31.51 | 37.87 | 334,298 | -9.98 | -23.59% |
| 1 Year | 34.05 | 50.26 | 25.925 | 37.42 | 383,112 | -1.73 | -5.08% |
| 3 Years | 66.60 | 83.45 | 20.03 | 44.43 | 459,922 | -34.28 | -51.47% |
| 5 Years | 8.23 | 85.10 | 8.08 | 40.98 | 410,575 | 24.09 | 292.71% |
REGENXBIO Description
| Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). |
